Trials / Sponsors / FutureGen Biopharmaceutical (Beijing) Co., Ltd
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer Pancreatic Cancer | Phase 3 | 2026-02-28 |
| Recruiting | M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negat Locally Advanced Unresectable or Metastatic Gastric Cancer, Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma | Phase 3 | 2023-12-25 |
| Unknown | Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresec Advanced Unresectable Solid Tumors | Phase 1 | 2021-06-11 |